NCT03009500View on ClinicalTrials.gov

Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

3

Participants

Timeline

Start Date

January 31, 2017

Primary Completion Date

March 31, 2018

Study Completion Date

June 30, 2019

Conditions
NeuralgiaPeripheral Neuropathic Pain
Interventions
DRUG

Bupivacaine

DRUG

Depo-Medrol Injectable Product

OTHER

Saline (Sodium Chloride) solution

DRUG

Lidocaine

Each injection of study medications will be preceded by subcutaneous injections of 1 mLs of 2% lidocaine at each injection site to reduce discomfort of the study participants from the injections

Trial Locations (1)

M5T 2S8

Toronto Western Hospital, Toronto

All Listed Sponsors
lead

University Health Network, Toronto

OTHER

NCT03009500 - Randomized Controlled Trial of Efficacy and Safety of Local Anesthetics and Steroids for Chronic Peripheral Post-traumatic Neuropathic Pain | Biotech Hunter | Biotech Hunter